טלפסט 120 מג ישראל - עברית - Ministry of Health

טלפסט 120 מג

pharma shalom - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 120 mg - fexofenadine - fexofenadine - relief of symptoms associated with seasonal allergic rhinitis

טלפסט 180 מג ישראל - עברית - Ministry of Health

טלפסט 180 מג

pharma shalom - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 180 mg - fexofenadine - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

פקסופנאדין-תרימה 120 מג ישראל - עברית - Ministry of Health

פקסופנאדין-תרימה 120 מג

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 120 mg - fexofenadine

פקסופנאדין-תרימה 180 מג ישראל - עברית - Ministry of Health

פקסופנאדין-תרימה 180 מג

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 180 mg - fexofenadine

פקסי 180 ישראל - עברית - Ministry of Health

פקסי 180

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - טבליות מצופות פילם - fexofenadine hydrochloride 180 mg - fexofenadine

טלפסט 180 מ"ג ישראל - עברית - Ministry of Health

טלפסט 180 מ"ג

sanofi - aventis israel ltd - fexofenadine hydrochloride 180 mg - film coated tablets - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

סנדוסטטין   0.1 מגמל ישראל - עברית - Ministry of Health

סנדוסטטין 0.1 מגמל

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

סנדוסטטין   0.05 מגמל ישראל - עברית - Ministry of Health

סנדוסטטין 0.05 מגמל

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

סנדוסטטין 0.5 מגמל ישראל - עברית - Ministry of Health

סנדוסטטין 0.5 מגמל

novartis israel ltd - octreotide - תמיסה להזרקה\אינפוזיה - octreotide 0.5 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: carcinoid tumours with features of the carcinoid syndrome. vipomas . glucagonomas . gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy . insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy . grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

אולתוטון 10 מג ישראל - עברית - Ministry of Health

אולתוטון 10 מג

abic marketing ltd, israel - octreotide as acetate - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - octreotide as acetate 10 mg - octreotide